Alan Snyder
Dermatology · Charleston, SCNPI 1184299893
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Sanofi at 52.8% of the total. Reporting peaked in 2023 at $7,395 and has fallen 67.1% since, to $2,432 in 2025.
Across 98 payments — averaging $133.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$7K
- Janssen Scientific Affairs, LLC$682
- UCB, Inc.$581
- Galderma Laboratories, L.p.$545
- AbbVie$474
- Sun Pharmaceutical Industries Inc.$429
- plus $3K from 20 others
What the payments were for
- Consulting fees$4,66136%
- Travel & lodging$8386%
- Food & beverage$7,15355%
- Education$4313%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 20 | $6,907 |
| Janssen Scientific Affairs, LLC | 6 | $682 |
| UCB, Inc. | 6 | $581 |
| Galderma Laboratories, L.p. | 5 | $545 |
| AbbVie | 8 | $474 |
| Sun Pharmaceutical Industries Inc. | 5 | $429 |
| Novartis | 4 | $365 |
| Johnson & Johnson | 7 | $340 |
| LEO Pharma Inc. | 3 | $324 |
| Arcutis Biotherapeutics, Inc. | 3 | $274 |
| Blueprint Medicines Corporation | 2 | $262 |
| Biofrontera Inc. | 2 | $249 |
| Boehringer Ingelheim | 2 | $241 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $227 |
| Lilly USA, LLC | 6 | $205 |
| Incyte Corporation | 2 | $154 |
| E.r. Squibb & Sons, L.L.C. | 2 | $136 |
| Amgen | 2 | $134 |
| Krystal Biotech Inc | 1 | $120 |
| Regeneron | 2 | $118 |
| Almirall LLC | 2 | $103 |
| Sanofi-aventis U.S. LLC | 1 | $90 |
| Dermavant Sciences, Inc. | 1 | $38 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Verrica Pharmaceuticals Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,083 in reported general payments places this provider in the 80th percentile of 203 dermatology providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 26 | $130,721 |
| Clobetasol Propionate | 24 | $781 |
| Triamcinolone Acetonide | 27 | $542 |
| Ketoconazole | 30 | $302 |
| Mometasone Furoate | 20 | $265 |
| ValacyclovirValacyclovir Hcl | 11 | $211 |
| Terbinafine Hcl | 12 | $81 |
| Hydrocortisone | 15 | $69 |
| Mupirocin | 12 | $54 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Charleston
- Todd SchlesingerCharleston$1.9M
- Mark SiegelCharleston$120K
- Erin WalkerCharleston$20K
- David SmithCharleston$12K
- Marshall ShulerGreenville$2.6M
- Rebecca SmithFort Mill$2.3M
- Amylynne FrankelSpartanburg$987K
- Marguerite GermainMt Pleasant$200K
- George KeoughPawleys Island$150K
- Christopher MartinAbbeville$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.